Lexeo Therapeutics Q1 2026 Earnings EPS Beat on Lower Operating Costs PAPL Q3 2025 Earnings NarrowerthanExpected Loss Boosts Sentiment Despite Negative Market Reaction DRCT Q1 2026 Earnings EPS Beats Estimates Despite Negative Results MRVL Q1 2026 Earnings Slight EPS Miss Despite Positive Market Response MATV Q1 2026 Earnings Significant EPS Beat Amid Cost Discipline and Strategic Focus Evolent Health Q1 2026 Earnings EPS Beat Drives Stock Rally